ERBB2 and breast cancer: We next tested the antitumor activity of paclitaxel using another HER2-overexpressing breast cancer cell line HCC1954 upon infection with the lentivirus containing pCDH-miR-125a, pCDH-miR-205, or pCDH-miRNA cluster.